Indoor Biotechnologies, Inc.

Indoor Biotechnologies is an immunodiagnostics and biotechnology company specializing in manufacturing innovative products for investigating allergy and asthma. The company is recognized as the world leader in assessment of environmental exposure to allergens - in the home, workplace, schools and commercial buildings. The company is at the forefront of research on allergen structure, molecular biology and immune response. Our mission is to improve the quality of life of patients with allergy and asthma.

Company details

1216 Harris Street , Charlottesville , Virginia 22903 USA

More Office Locations Locations Served

Business Type:
Manufacturer
Industry Type:
Workplace Safety
Market Focus:
Globally (various continents)

Indoor Biotechnologies is privately held and organized as two affiliated companies, INDOOR Biotechnologies Inc. (IBI), located in Charlottesville, Virginia, USA, and INDOOR Biotechnologies Limited (IBL) based in Warminster, UK. IBI carries out research, development and sales in the Americas.  IBL handles sales, distribution and business development in Europe, the Far East, Australia and New Zealand.  Indoor Biotechnologies has a global presence, with authorized distributors in Japan, China, South Korea, Australia and New Zealand and sales in 35 different countries.  Indoor Biotechnologies is an entrepreneurial company that couples innovative science with a creative approach to business to add value through technology.

Indoor Biotechnologies core technology is a comprehensive, proprietary portfolio of antibodies for the detection of house dust mite, cat, dog, cockroach, mold, pollen and food allergens.  These antibodies are key components in assay platforms including ELISA and MARIA­­ technology for allergen detection and our Ventia rapid allergen test.

Indoor Biotechnologies has a complete range of tests for assessing environmental exposure to indoor allergens; for testing the efficacy of allergen avoidance procedures, products and devices, for allergen standardization and for new product development.

Indoor Biotechnologies also manufactures purified natural and recombinant allergens for research use and for development of allergy diagnostics and vaccines. This product line currently includes fifty purified allergens that are manufactured to a high degree of purity and biologic activity.  The line includes purified LoTox allergens with low endotoxin content that are designed for immunologic studies of allergy and asthma.

Indoor Biotechnologies was founded by Dr. Martin D. Chapman, formerly Professor of Medicine and Microbiology at the University of Virginia and a member of the UVA Asthma and Allergic Diseases Center. Dr. Chapman is a Fellow of the American Academy of Allergy, Asthma and Immunology and has served as a consultant to the U.S. National Institutes of Health, the Environmental Protection Agency, academic institutions and Fortune 500 companies..

Indoor Biotechnologies specializes in manufacturing biologics for allergy and asthma. The company is recognized as the world leader in assessment of environmental exposure to allergens - in the home, workplace, schools and commercial buildings. The company manufactures highly purified allergens for allergy research and diagnostics, and is internationally recognized for research on allergen structure, function and immune recognition. Indoor Biotechnologies mission is to improve the quality of life of patients with allergy and asthma.

Indoor Biotechnologies is organized as three affiliated companies, INDOOR Biotechnologies Inc. (IBI), located in Charlottesville, Virginia, USA, INDOOR Biotechnologies Limited (IBL) based in Cardiff, UK and INDOOR Biotechnologies India (IBIndia), newly established in Bangalore. Indoor Biotechnologies has a global presence, with authorized distributors in Japan, China, and Korea, with sales in ~50 countries worldwide. Indoor Biotechnologies is an entrepreneurial company that couples innovative science with a creative approach to business, adding value through technology.

Indoor Biotechnologies' core technology is a comprehensive, proprietary portfolio of antibodies for the detection of house dust mite, cat, dog, cockroach, mold, pollen and food allergens. These antibodies are key components in assay platforms including ELISA kits and MARIA® technology for allergen detection. MARIA® is state-of-the-art multiplex testing for environmental allergens. Indoor Biotechnologies laboratories in Charlottesville and in Cardiff are ISO 17025 compliant and provide a comprehensive range of environmental testing services.

Indoor Biotechnologies manufactures purified natural and recombinant allergens for research and for development of allergy diagnostics and vaccines. This product line currently includes fifty purified allergens that are manufactured to a high degree of purity and biologic activity. This includes LoTox™ allergens with low endotoxin content that are designed for immunologic studies of allergy and asthma.

Indoor Biotechnologies clients include leading allergists, immunologists, academic and government researchers in the US, Europe, Asia, South America and Australasia. Our ELISA and MARIA kits have been used for assessing allergen exposure in epidemiologic studies of asthma carried out by the U.S. National Institutes of Health; the Centers for Disease Control and Prevention; the Department of Housing and Urban Development; and the Food and Drug Administration. In Europe, Indoor Biotechnologies products have been used in the European Union CREATE project on allergen standardization, in the European Community Respiratory Health Survey and in several large birth cohort studies at academic medical centers and universities.

Indoor Biotechnologies commercial clients include pharmaceutical and biotechnology companies, allergen manufacturers, household cleaning products companies, indoor air quality and environmental companies, and industrial hygienists. In the U.S., the vast majority of indoor air quality companies that test for allergens use Indoor Biotechnologies ELISA kits for allergen exposure assessment.

Indoor Biotechnologies clients also include consumers. Indoor Biotechnologies Ventia™ rapid test for dust mites is available on Amazon.com. Ventia includes our patented DUSTREAM® collector for easy collection and processing of dust samples in the home. Indoor Biotechnologies is dedicated to customer service and provides high quality service, product support, flexibility and consideration to all of our customers.

The principles upon which Indoor Biotechnologies operates and which guide our behaviors are based on: 

  • Trust
  • Integrity
  • Commitment to Excellence
  • Leadership
  • Communication